PMID- 23001598
OWN - NLM
STAT- MEDLINE
DCOM- 20130820
LR  - 20211021
IS  - 1708-0428 (Electronic)
IS  - 0960-8923 (Linking)
VI  - 23
IP  - 2
DP  - 2013 Feb
TI  - Indications and mid-term results of conversion from sleeve gastrectomy to 
      Roux-en-Y gastric bypass.
PG  - 212-5
LID - 10.1007/s11695-012-0782-1 [doi]
AB  - Sleeve gastrectomy (SG) is currently considered as a primary bariatric surgery. 
      This is because of its relative simplicity and satisfactory results. As observed 
      with other bariatric procedures, surgeons are confronted with insufficient weight 
      loss or weight regain, insufficient resolution of metabolic disorders, and 
      intractable severe reflux. A retrospective analysis of conversion from SG to 
      Roux-en-Y gastric bypass (RYGBP) was performed to assess weight loss, diabetes 
      resolution, and relief of reflux symptoms. The mean interval between the two 
      procedures was almost 24 months. Eighteen patients underwent conversion from SG 
      to RYGBP for insufficient weight loss (n = 9), severe reflux (n = 6), and 
      persistence of type 2 diabetes mellitus (T2DM) (n = 3). The median follow-up was 
      15.5 months. Weight loss was significantly improved with a mean percentage of 
      excess of body mass index loss at 64.6 % after conversion versus 47.1 % before 
      conversion. All reflux symptoms were immediately relieved without any medication 
      at the end of the follow-up. The three patients who had an operation for 
      persistence of T2DM are now free of medication. Only one postoperative 
      complication was observed as a small bowel injury, which was treated surgically. 
      Conversion from SG to RYGBP is safe. Severe reflux is definitely treated and is 
      an incontestable indication with this procedure. Additionally, weight loss and 
      diabetes are clinically improved. Our results appear to be similar to those with 
      a primary RYGBP.
FAU - Gautier, Thomas
AU  - Gautier T
AD  - Departement de Chirurgie Digestive, Caen University Hospital, Avenue de la Cote 
      de Nacre, 14033, Caen Cedex, France. gautier.tho@gmail.com
FAU - Sarcher, Thomas
AU  - Sarcher T
FAU - Contival, Nicolas
AU  - Contival N
FAU - Le Roux, Yannick
AU  - Le Roux Y
FAU - Alves, Arnaud
AU  - Alves A
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Obes Surg
JT  - Obesity surgery
JID - 9106714
SB  - IM
MH  - Adult
MH  - Body Mass Index
MH  - Diabetes Mellitus, Type 2/epidemiology/*surgery
MH  - Female
MH  - France/epidemiology
MH  - *Gastric Bypass/methods
MH  - Gastroesophageal Reflux/epidemiology/*surgery
MH  - *Gastroplasty/adverse effects/methods
MH  - Humans
MH  - *Laparoscopy/adverse effects/methods
MH  - Male
MH  - Middle Aged
MH  - Obesity, Morbid/epidemiology/physiopathology/*surgery
MH  - Patient Satisfaction/statistics & numerical data
MH  - Remission Induction
MH  - Reoperation/statistics & numerical data
MH  - Retrospective Studies
MH  - Risk Assessment
MH  - Time Factors
MH  - Treatment Failure
MH  - Weight Gain
MH  - Weight Loss
MH  - Young Adult
EDAT- 2012/09/25 06:00
MHDA- 2013/08/21 06:00
CRDT- 2012/09/25 06:00
PHST- 2012/09/25 06:00 [entrez]
PHST- 2012/09/25 06:00 [pubmed]
PHST- 2013/08/21 06:00 [medline]
AID - 10.1007/s11695-012-0782-1 [doi]
PST - ppublish
SO  - Obes Surg. 2013 Feb;23(2):212-5. doi: 10.1007/s11695-012-0782-1.